ArticleOncoimmunology2020

MIF inhibition as a strategy for overcoming resistance to immune checkpoint blockade therapy in melanoma.

Ricardo A de Azevedo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.